Does real-time glucose tracking before surgery cut complications? a massive trial puts it to the test.
NCT ID NCT06331923
First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time
Summary
This trial tests whether using a continuous glucose monitor (CGM) before and after major surgery can reduce complications in adults with diabetes or impaired glucose tolerance. Participants wear the device for at least 6 hours before surgery and up to 7 days after, while a comparison group receives standard glucose checks. The goal is to see if CGM leads to fewer and less severe complications within 30 days after surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- continuous glucose monitoring (CGM) device
- What this could lead to
- If effective, CGM could become a standard tool to reduce post-surgical complications in people with diabetes.
- What could go wrong
- This is a large pragmatic trial, but the benefit of CGM over conventional monitoring in surgical settings is not yet proven, and device calibration or patient adherence may affect results.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COMPREHENSIVE COMPLICATION INDEX are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Tsinghua Changgung Hospital
Beijing, Beijing Municipality, 102218, China
-
Department of Anesthesiology, Emergency General Hospital
Beijing, China
-
Department of Anesthesiology, Peking University International Hospital
Beijing, China
-
Department of Anesthesiology, Peking University Shougang Hospital
Beijing, China
-
Department of Anesthesiology, Yueyang Central Hospital
Hunan, China
-
Department of Endocrinology and Metabolism, Fuzhou First General Hospital Affiliated with Fujian Medical University
Fuzhou, China
-
Department of Endocrinology and Metabolism, The Second Hospital of Shanxi Medical University
Shanxi, China
-
Department of Endocrinology, Jilin Chemical Hospital
Jilin City, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- FitBit coaching may help amputees walk more after surgery
- Can AI catch the leading cause of blindness before It's too late?
- Does feeling stigmatized worsen life quality for men with low testosterone?
- Can community hospitals in zambia master severe disease care?
- Can a wearable sensor beat Finger-Prick tests for type 2 diabetes?
- Brain training may sharpen aging minds in diabetes